Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$531.42 USD
+6.23 (1.19%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $531.59 +0.17 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum B VGM
Company Summary
Based in Indianapolis, IN, Elevance Health is one of the largest publicly traded health insurers in the United States, in terms of membership. The company was previously named Anthem, Inc. Effective Jun 27, 2022, the corporate name was changed to Elevance Health and began trading under the ticker “ELV” on Jun 28.
The company is an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Medical membership of Elevance Health as of Dec 31, 2023, totaled 47 million. With the latest name change the company announced a rejig of its brand portfolio. The company is expected to ...
Company Summary
Based in Indianapolis, IN, Elevance Health is one of the largest publicly traded health insurers in the United States, in terms of membership. The company was previously named Anthem, Inc. Effective Jun 27, 2022, the corporate name was changed to Elevance Health and began trading under the ticker “ELV” on Jun 28.
The company is an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Medical membership of Elevance Health as of Dec 31, 2023, totaled 47 million. With the latest name change the company announced a rejig of its brand portfolio. The company is expected to organize its brand portfolio into Anthem Blue Cross/Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon core go-to-market brands. The company markets its products through agents, brokers and retail partnerships.
Elevance Health currently operates through three reportable segments:
Health Benefits (aggregation of the previously known Commercial & Specialty Business and Government Business), Carelon (includes CarelonRx and Carelon Services), and Corporate & Other.
Health Benefits (generated 87.3% of 2023 total operating revenues) now encompasses group risk-based and fee-based, Individual and BlueCard businesses. It offers administrative managed care services to fee-based clients. Furthermore, this unit offers products like vision, dental, life, disability and supplemental health insurance benefits. Also, the segment consists of Medicaid, Medicare businesses and National Government Services.
Carelon (28.2%) comprises CarelonRx (previously IngenioRx) and Carelon Services (previously Diversified Business Group). The healthcare services brand Carelon was launched in June 2022 as part of ELV’s rebranding process. CarelonRx markets and offers PBM services to health plan clients as well as external customers. The PBM service portfolio incorporates services like pharmacy networks, formulary management, prescription drug database, member services and others.
Corporate & Other (0.3%) comprises businesses that cannot meet the quantitative threshold of other segments. It also includes corporate expenses which cannot be allocated to other segments.
(The total percentage of the segments' operating revenues will not be equal to 100% due to eliminations.)
General Information
Elevance Health, Inc
220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204
Phone: 833-401-1577
Fax: 317-488-6275
Web: http://www.elevancehealth.com
Email: investor.relations@elevancehealth.com
Industry | Medical Services |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 3/31/2024 |
Exp Earnings Date | 7/17/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 10.21 |
Current Year EPS Consensus Estimate | 37.03 |
Estimated Long-Term EPS Growth Rate | 12.30 |
Exp Earnings Date | 7/17/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 525.19 |
52 Week High | 539.11 |
52 Week Low | 412.00 |
Beta | 0.78 |
20 Day Moving Average | 1,015,898.81 |
Target Price Consensus | 578.71 |
4 Week | 2.04 |
12 Week | 9.34 |
YTD | 11.37 |
4 Week | 6.74 |
12 Week | 6.79 |
YTD | 6.01 |
Shares Outstanding (millions) | 232.70 |
Market Capitalization (millions) | 122,211.71 |
Short Ratio | NA |
Last Split Date | 6/1/2005 |
Dividend Yield | 1.24% |
Annual Dividend | $6.52 |
Payout Ratio | 0.18 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | 3/7/2024 / $1.63 |
Fundamental Ratios
P/E (F1) | 14.18 |
Trailing 12 Months | 15.32 |
PEG Ratio | 1.15 |
vs. Previous Year | 7.46% |
vs. Previous Quarter | -37.49% |
vs. Previous Year | 6.81% |
vs. Previous Quarter | -0.47% |
Price/Book | 3.00 |
Price/Cash Flow | 12.73 |
Price / Sales | 0.71 |
3/31/24 | NA |
12/31/23 | 20.47 |
9/30/23 | 20.72 |
3/31/24 | NA |
12/31/23 | 7.19 |
9/30/23 | 7.24 |
3/31/24 | NA |
12/31/23 | 1.44 |
9/30/23 | 1.41 |
3/31/24 | NA |
12/31/23 | 1.44 |
9/30/23 | 1.41 |
3/31/24 | NA |
12/31/23 | 4.59 |
9/30/23 | 4.63 |
3/31/24 | NA |
12/31/23 | 3.49 |
9/30/23 | 3.61 |
3/31/24 | NA |
12/31/23 | 4.50 |
9/30/23 | 4.60 |
3/31/24 | NA |
12/31/23 | 169.07 |
9/30/23 | 164.02 |
3/31/24 | NA |
12/31/23 | NA |
9/30/23 | NA |
3/31/24 | NA |
12/31/23 | 0.59 |
9/30/23 | 0.62 |
3/31/24 | NA |
12/31/23 | 37.10 |
9/30/23 | 38.42 |